NovoCure (NVCR) Institutional Ownership $17.90 +0.15 (+0.85%) Closing price 04:00 PM EasternExtended Trading$17.99 +0.09 (+0.50%) As of 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NovoCure (NASDAQ:NVCR)CurrentInstitutional OwnershipPercentage84.61%Number ofInstitutional Buyers(last 12 months)136TotalInstitutional Inflows(last 12 months)$344.12MNumber ofInstitutional Sellers(last 12 months)84TotalInstitutional Outflows(last 12 months)$1.39B Get NVCR Insider Trade Alerts Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NVCR Institutional Buying and Selling by Quarter NovoCure Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE170,013$1.85M0.0%-50.4%0.147% 5/18/2026 Amundi47,583$519K0.0%+19.9%0.041% 5/18/2026 California State Teachers Retirement System142,561$1.55M0.0%+43.6%0.123% 5/18/2026 Royal Bank of Canada9,211$100K0.0%-28.2%0.008% 5/18/2026 Eversept Partners LP134,917$1.47M0.1%+11.5%0.116% 5/16/2026 The Manufacturers Life Insurance Company 39,598$432K0.0%-4.1%0.034% 5/16/2026 Quantinno Capital Management LP2,487,376$27.11M0.0%+23.7%2.148% 5/14/2026 Healthcare of Ontario Pension Plan Trust Fund726,400$7.92M0.0%-21.7%0.627% 5/14/2026 Renaissance Technologies LLC1,551,554$16.91M0.0%+11.8%1.340% 5/14/2026 Arrowstreet Capital Limited Partnership28,130$307K0.0%N/A0.024% Get the Latest News and Ratings for NVCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. 5/14/2026 Sei Investments Co.114,281$1.25M0.0%+367.6%0.099% 5/13/2026 First Trust Advisors LP94,293$1.03M0.0%N/A0.081% 5/7/2026 Dimensional Fund Advisors LP960,056$10.46M0.0%+27.6%0.829% 5/6/2026 Kera Capital Partners Inc.21,454$234K0.0%+9.0%0.019% 5/5/2026 Bank of New York Mellon Corp281,471$3.07M0.0%-5.7%0.243% 5/5/2026 Hillsdale Investment Management Inc.121,800$1.33M0.0%-7.6%0.105% 5/4/2026 Calamos Wealth Management LLC24,954$272K0.0%N/A0.022% 5/4/2026 Calamos Advisors LLC24,954$272K0.0%N/A0.022% 5/4/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management18,140$198K0.0%N/A0.016% 5/4/2026 Chicago Partners Investment Group LLC20,101$219K0.0%-17.7%0.017% 4/30/2026 Hsbc Holdings PLC31,690$342K0.0%-32.3%0.027% 4/27/2026 Counterpoint Mutual Funds LLC49,382$538K0.1%+27.9%0.043% 4/27/2026 Y Intercept Hong Kong Ltd127,780$1.39M0.0%-16.8%0.110% 4/25/2026 Strs Ohio59,400$647K0.0%+2.2%0.051% 4/22/2026 Pictet Asset Management Holding SA19,845$216K0.0%+23.8%0.017% 4/22/2026 Venturi Wealth Management LLC11,266$123K0.0%N/A0.010% 4/16/2026 SG Americas Securities LLC1,245,541$13.58M0.0%+346.7%1.095% 3/20/2026 Hsbc Holdings PLC46,781$614K0.0%-15.0%0.041% 3/9/2026 Corient Private Wealth LLC46,952$608K0.0%+34.0%0.041% 2/23/2026 Kera Capital Partners Inc.19,691$244K0.0%+84.4%0.018% 2/19/2026 T. Rowe Price Investment Management Inc.3,143$41K0.0%-99.7%0.003% 2/19/2026 Invesco Ltd.67,968$879K0.0%-10.3%0.061% 2/19/2026 Corient Private Wealth LLC97,368$1.26M0.0%+178.0%0.087% 2/18/2026 Mercer Global Advisors Inc. ADV32,660$422K0.0%+14.5%0.029% 2/18/2026 Empowered Funds LLC2,559$33K0.0%N/A0.002% 2/18/2026 XTX Topco Ltd58,795$760K0.0%+159.2%0.053% 2/18/2026 Voloridge Investment Management LLC407,204$5.27M0.0%-35.5%0.364% 2/18/2026 Vestal Point Capital LP525,000$6.79M0.2%+31.3%0.469% 2/18/2026 Susquehanna Portfolio Strategies LLC289,359$3.74M0.1%+981.7%0.258% 2/18/2026 Tudor Investment Corp ET AL284,645$3.68M0.0%-53.0%0.254% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…Click here to watch this short 3-minute video now.2/18/2026 Twinbeech Capital LP11,330$146K0.0%N/A0.010% 2/18/2026 Polymer Capital Management US LLC13,625$176K0.0%N/A0.012% 2/18/2026 Numerai GP LLC51,218$662K0.1%N/A0.046% 2/18/2026 Millennium Management LLC646,666$8.36M0.0%-51.6%0.577% 2/18/2026 Engineers Gate Manager LP291,332$3.77M0.0%+6.6%0.260% 2/18/2026 Eversept Partners LP120,978$1.56M0.1%N/A0.108% 2/18/2026 Balyasny Asset Management L.P.31,339$405K0.0%N/A0.028% 2/18/2026 Boothbay Fund Management LLC50,542$654K0.0%N/A0.045% 2/17/2026 ADAR1 Capital Management LLC34,000$440K0.0%-46.9%0.030% 2/17/2026 Schonfeld Strategic Advisors LLC144,728$1.87M0.0%+364.9%0.129% 2/17/2026 PDT Partners LLC22,252$288K0.0%N/A0.020% 2/17/2026 AQR Capital Management LLC414,742$5.36M0.0%+110.7%0.370% 2/17/2026 Amundi39,676$513K0.0%+11.0%0.035% 2/17/2026 Jump Financial LLC561,237$7.26M0.1%+159.3%0.501% 2/17/2026 Price T Rowe Associates Inc. MD94,094$1.22M0.0%-14.7%0.084% 2/17/2026 T. Rowe Price Investment Management Inc.3,143$41K0.0%-99.7%0.003% 2/17/2026 California State Teachers Retirement System99,304$1.28M0.0%-4.7%0.089% 2/17/2026 Russell Investments Group Ltd.155,199$2.01M0.0%-95.5%0.139% 2/17/2026 Captrust Financial Advisors10,646$138K0.0%N/A0.010% 2/17/2026 Royal Bank of Canada12,830$166K0.0%+14.9%0.011% 2/17/2026 Graham Capital Management L.P.38,857$502K0.0%+284.9%0.035% 2/16/2026 Squarepoint Ops LLC53,045$686K0.0%-35.4%0.047% 2/16/2026 Verition Fund Management LLC168,873$2.18M0.0%-94.5%0.151% 2/16/2026 Walleye Trading LLC25,808$334K0.0%N/A0.023% 2/16/2026 Mariner LLC20,368$264K0.0%-13.5%0.018% 2/16/2026 Healthcare of Ontario Pension Plan Trust Fund927,400$11.99M0.0%N/A0.828% 2/16/2026 Arax Advisory Partners21,933$284K0.0%-36.9%0.020% 2/16/2026 Barclays PLC447,255$5.78M0.0%+12.4%0.399% 2/13/2026 Kestra Advisory Services LLC3,763$49K0.0%N/A0.003% 2/13/2026 The Manufacturers Life Insurance Company 41,303$534K0.0%-3.9%0.037% 2/13/2026 Walleye Capital LLC11,676$151K0.0%-94.6%0.010% 2/13/2026 Morgan Stanley5,069,895$65.55M0.0%+453.4%4.528% 2/13/2026 Schroder Investment Management Group1,019,969$13.48M0.0%+129.3%0.911% 2/13/2026 Jacobs Levy Equity Management Inc.1,223,755$15.82M0.1%+1,093.2%1.093% 2/13/2026 Headlands Technologies LLC23,700$306K0.0%-55.2%0.021% 2/13/2026 Birchview Capital LP152,100$1.97M1.2%+49.0%0.136% 2/13/2026 Charles Schwab Investment Management Inc.876,816$11.34M0.0%-3.7%0.783% 2/13/2026 State Street Corp2,577,239$33.32M0.0%-81.3%2.302% 2/13/2026 Ieq Capital LLC378,974$4.90M0.0%+568.6%0.338% 2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC226,500$2.93M0.0%-81.1%0.202% 2/12/2026 Soleus Capital Management L.P.8,530,665$110.30M4.1%-11.6%7.618% 2/12/2026 Hohimer Wealth Management LLC23,250$301K0.0%-69.6%0.021% 2/12/2026 HRT Financial LP250,862$3.24M0.0%-31.0%0.224% 2/12/2026 MetLife Investment Management LLC56,930$736K0.0%-9.2%0.051% 2/12/2026 Renaissance Technologies LLC1,387,754$17.94M0.0%+29.4%1.239% 2/12/2026 Dimensional Fund Advisors LP752,143$9.73M0.0%+32.9%0.672% 2/12/2026 Counterpoint Mutual Funds LLC38,605$499K0.0%+23.1%0.034% 2/12/2026 Federated Hermes Inc.115,136$1.49M0.0%+9.2%0.103% 2/12/2026 Ensign Peak Advisors Inc6,737$87K0.0%-76.0%0.006% 2/12/2026 Campbell & CO Investment Adviser LLC49,367$638K0.0%+65.9%0.044% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…Click here to watch this short 3-minute video now.2/12/2026 Swiss National Bank209,500$2.71M0.0%+2.0%0.187% 2/12/2026 Nuveen LLC1,273,349$16.46M0.0%-25.4%1.137% 2/11/2026 Empowered Funds LLC2,559$33K0.0%N/A0.002% 2/11/2026 Inceptionr LLC16,077$208K0.1%-7.6%0.014% 2/11/2026 Deutsche Bank AG314,080$4.06M0.0%+260.1%0.280% 2/11/2026 Fox Run Management L.L.C.99,405$1.29M0.2%+112.3%0.089% 2/11/2026 LPL Financial LLC16,380$212K0.0%+15.1%0.015% 2/11/2026 Franklin Resources Inc.264,894$3.43M0.0%+5.8%0.237% 2/11/2026 JPMorgan Chase & Co.402,882$5.21M0.0%+42.8%0.360% 2/11/2026 Syon Capital LLC17,451$226K0.0%+27.7%0.016% NVCR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCR shares? During the previous two years, 238 institutional investors and hedge funds held shares of NovoCure. The most heavily invested institutionals were FMR LLC ($483.66M), Capital International Investors ($264.44M), Vanguard Group Inc. ($141.69M), Soleus Capital Management L.P. ($110.30M), Morgan Stanley ($65.55M), State Street Corp ($33.32M), and Geode Capital Management LLC ($32.03M).Learn more on NovoCure's institutional investors. What percentage of NovoCure's stock is owned by institutional investors? 84.61% of NovoCure's stock is owned by institutional investors. Learn more on NVCR's institutional investor holdings. Which institutional investors have been buying NovoCure's stock? Of the 210 institutional investors that purchased NovoCure's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Morgan Stanley ($4.15M), Soleus Capital Management L.P. ($4.12M), Nordwand Advisors LLC ($1.51M), SG Americas Securities LLC ($1.28M), American Century Companies Inc. ($1.22M), UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC ($1.17M), and Jacobs Levy Equity Management Inc. ($1.12M). How much institutional buying is happening at NovoCure? Institutional investors have bought a total of 24,812,134 shares in the last 24 months. This purchase volume represents approximately $344.12M in transactions. Which of NovoCure's major shareholders have been selling company stock? Of the 84 institutional investors that sold NovoCure's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Voya Investment Management LLC ($64.54M), State Street Corp ($11.21M), BNP Paribas Financial Markets ($10.96M), Capital World Investors ($4.38M), Russell Investments Group Ltd. ($3.28M), Verition Fund Management LLC ($2.93M), and T. Rowe Price Investment Management Inc. ($1.88M). How much institutional selling is happening at NovoCure? Institutional investors have sold a total of 107,249,017 shares in the last 24 months. This volume of shares sold represents approximately $1.39B in transactions. Related Companies Bausch + Lomb Major Shareholders Stevanato Group Major Shareholders Liquidia Major Shareholders LivaNova Major Shareholders Envista Major Shareholders iRhythm Technologies Major Shareholders Warby Parker Major Shareholders Soleno Therapeutics Major Shareholders LeMaitre Vascular Major Shareholders TransMedics Group Major Shareholders This page (NASDAQ:NVCR) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
